Feb 14, 2023 / 04:00PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director
I'm Yigal Nochomovitz. I'm one of the biotech analysts here at Citi. This is a continuation of our newly introduced C-suite series where we feature management from some of our covered companies for a 1-hour discussion about the pipeline and other topics.
So it's my great pleasure to have with me this morning, Josh Smiley, who is the COO of Zai Lab. Josh started in August of 2022 after a 26-year career at Lilly. (Operator Instructions) So Josh, welcome. Thank you so much for taking the time to speak with us for an hour. I appreciate it.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - DirectorI think a lot of people are familiar with Zai Lab, but I think a lot of people also aren't. So I think maybe to start with, if you could just outline the strategic vision for the company over the next, say, 5 or 10 years. How do you see the mission evolving, both in the pipeline as well as the commercial side? And how do you see the transformation of Zai
Trustpilot
